Study details
Enrolling now
Cocoa Extract for Migraine Trial
Brigham and Women's Hospital
NCT IDNCT06808230ClinicalTrials.gov data as of Apr 2026
Target enrollment
114
Study length
about 1.4 years
Ages
18+
Locations
1 site in MA
About this study
This trial is testing if cocoa extract can help with migraines. Participants will take either cocoa extract or a placebo daily and provide urine samples and answer questionnaires.
Based on ClinicalTrials.gov records.
What participants do
- 1.Cocoa extract
- 2.Cocoa extract placebo
DrugCocoa extract
Primary goalAdherence
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
Dermatological Agents (Immunologic Factor Interactions)
Endpoints
Primary: Adherence, Recruitment, Retention
Secondary: Adverse events, Allodynia Symptom Checklist, PROMIS-29, Reports of worsening of migraine symptoms
Body systems
Neurology